Characterizing drug-induced capillary leak syndromes using the World Health Organization VigiBase

J Allergy Clin Immunol. 2019 Jan;143(1):433-436. doi: 10.1016/j.jaci.2018.09.001. Epub 2018 Sep 20.
No abstract available

Publication types

  • Letter
  • Observational Study

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Capillary Leak Syndrome / chemically induced*
  • Capillary Leak Syndrome / epidemiology*
  • Capillary Leak Syndrome / immunology
  • Databases, Factual*
  • Humans
  • Immunologic Factors / administration & dosage
  • Immunologic Factors / adverse effects*
  • Male
  • Retrospective Studies
  • World Health Organization

Substances

  • Antineoplastic Agents
  • Immunologic Factors

Associated data

  • ClinicalTrials.gov/NCT03480529